Safety and Efficacy of Aloe Vera in the Management of the Symptoms of Interstitial Cystitis
Trial statusRecruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age18-80
SponsorWake Forest University Health Sciences
About this trial
The purpose of this study is to assess the safety and efficacy of super-concentrated, freeze-dried aloe vera capsules for treatment of interstitial cystitis.
Eligibility criteria
Qualifiers
Females or males, aged 18 years or older
Females of childbearing potential must agree to use acceptable methods of birth control. Acceptable methods are oral and injectable preparations, double barrier, vasectomized partner, or abstinence.
Participant must sign and date the informed consent.
Participant must report a urinary frequency of at least 11 times per 24-hour day, on average over the previous four weeks.
Disqualifiers
Known allergy or intolerance to aloe vera in any form as reported by the participant or derived from medical records.
History of Bladder tumors (malignant or benign).
Current active bladder or urethral calculus.
History of urethral cancer within the previous five years.
Trial design
Treatments tested in this trial
- Desert Harvest Aloe Vera Capsules
- Placebo Capsules
Treatment groups
30 Participants
are divided into 2 treatment groupsSponsors and collaborators
Wake Forest University Health Sciences
Lead sponsor
Desert Harvest
Collaborator
Source ClinicalTrials.gov